i
Decision and cost-effectiveness analyses of Herpes zoster vaccination in adults 50 years of age and older
-
October 23, 2013
Details:
-
Personal Author:
-
Corporate Authors:
-
Conference Authors:
-
Subjects:
-
Series:
-
Document Type:
-
Name as Subject:
-
Genre:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: